Priorityreviewvoucher
About Priorityreviewvoucher
Priorityreviewvoucher is a Healthcare company, and was acquired by Biohaven Pharmaceutical in March 2019. Priority review vouchers are supplied for expedited drug approvals. Priorityreviewvoucher offers products and services including Priority Review Voucher Program. Its focus areas include Services for Healthcare Providers.
Company details
Priority review vouchers are issued by Priorityreviewvoucher to facilitate accelerated regulatory reviews of pharmaceutical products. Treatments for neglected diseases, rare pediatric conditions, or medical countermeasures qualify developers for these vouchers, which can be transferred or sold to hasten approvals for other drugs. The initiative encourages innovation in underserved areas while shortening market entry timelines for new therapies. Operations focus on the pharmaceutical sector, with no fixed expiration for the program.
- Stage Acquired
- SectorsHealthcare
- Website priorityreviewvoucher.org
- Acquired by Biohaven Pharmaceutical (Mar 2019)
- Investors
- Acquired byBiohaven Pharmaceutical
(Mar 2019)
Products & Services of Priorityreviewvoucher
Priorityreviewvoucher offers a comprehensive portfolio of products and services, including Priority Review Voucher Program.
Incentive for faster FDA drug approvals
Investors in Priorityreviewvoucher
Priorityreviewvoucher has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Biohaven Pharmaceutical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Therapies for neurological and neuropsychiatric diseases are developed. | 2014 | biohavenpharma.com | New Haven, United States |
Investor details for Priorityreviewvoucher
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Priorityreviewvoucher
Priority review vouchers are issued by Priorityreviewvoucher to facilitate accelerated regulatory reviews of pharmaceutical products. Treatments for neglected diseases, rare pediatric conditions, or medical countermeasures qualify developers for these vouchers, which can be transferred or sold to hasten approvals for other drugs. The initiative encourages innovation in underserved areas while shortening market entry timelines for new therapies. Operations focus on the pharmaceutical sector, with no fixed expiration for the program.
Priorityreviewvoucher offers Priority Review Voucher Program.
Priorityreviewvoucher has 1 investor. Key investors include Biohaven Pharmaceutical.
Yes. Priorityreviewvoucher was acquired by Biohaven Pharmaceutical in March 2019.